Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

INDV

Indivior Plc

May 10 • 04:00PM ET

17.73

Dollar change -0.14
Percentage change -0.78	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: PDN DFAX

Scroll to Statements

Index	-	P/E	1465.29	EPS (ttm)	0.01	Insider Own	0.68%	Shs Outstand	136.53M	Perf Week	-1.23%
Market Cap	2.40B	Forward P/E	6.92	EPS next Y	2.56	Insider Trans	0.00%	Shs Float	134.32M	Perf Month	-12.83%
Income	5.00M	PEG	-	EPS next Q	0.44	Inst Own	72.06%	Short Float	0.13%	Perf Quarter	0.00%
Sales	1.12B	P/S	2.13	EPS this Y	28.03%	Inst Trans	-	Short Ratio	1.27	Perf Half Y	-8.11%
Book/sh	0.07	P/B	240.93	EPS next Y	27.42%	ROA	0.31%	Short Interest	0.17M	Perf Year	-2.58%
Cash/sh	2.44	P/C	7.27	EPS next 5Y	-	ROE	12.20%	52W Range	14.38 - 26.50	Perf YTD	16.11%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-62.20%	ROI	1.81%	52W High	-33.09%	Beta	0.74
Dividend TTM	-	Quick Ratio	0.74	Sales past 5Y	3.60%	Gross Margin	81.14%	52W Low	23.29%	ATR (14)	0.58
Dividend Ex-Date	Jun 16, 2016	Current Ratio	0.92	EPS Y/Y TTM	111.00%	Oper. Margin	1.16%	RSI (14)	38.38	Volatility	2.07% 2.74%
Employees	1164	Debt/Eq	27.90	Sales Y/Y TTM	18.57%	Profit Margin	0.44%	Recom	1.00	Target Price	32.30
Option/Short	Yes / Yes	LT Debt/Eq	26.70	EPS Q/Q	8.55%	Payout	-	Rel Volume	0.42	Prev Close	17.87
Sales Surprise	-5.25%	EPS Surprise	-10.84%	Sales Q/Q	12.25%	Earnings	Apr 25 BMO	Avg Volume	136.77K	Price	17.73
SMA20	-3.19%	SMA50	-11.67%	SMA200	-8.66%	Trades		Volume	58,018	Change	-0.78%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-03-24	Initiated	Craig Hallum	Buy	$37
Jul-13-23	Initiated	Northland Capital	Outperform	$35

Apr-26-24 01:01PM	Indivior PLC (INDV) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
Apr-25-24 07:53AM	INDV Stock Earnings: Indivior Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -8.29%
07:05AM	Indivior PLC (INDV) Q1 Earnings and Revenues Lag Estimates (Zacks)
04:38AM	UPDATE 1-UK-listed drugmaker Indivior seeks shareholder nod for US listing (Reuters)
03:48AM	Drugmaker Indivior to seek shareholder nod on shifting primary listing to US (Reuters)
03:44AM	Loading…
03:44AM	Indivior Confirms Plan to Switch Listing From London to New York (Bloomberg)
02:00AM	Indivior Announces Q1 2024 Financial Results (PR Newswire)
Apr-04-24 09:27AM	Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains? (Zacks)
Mar-19-24 09:55AM	Indivior PLC (INDV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Mar-11-24 02:43PM	Indivior Announces Publication Demonstrating that OPVEE (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone (PR Newswire)
Mar-07-24 11:56AM	Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 02:02AM	Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation (PR Newswire)
Feb-23-24 06:54AM	Health Care Roundup: Market Talk (The Wall Street Journal)
Feb-22-24 06:02AM	London Risks Losing Another Major Company to New York Stock Exchange (Bloomberg) +21.71%
05:21AM	Fresh blow for London market as drug maker joins exodus to New York (The Telegraph)
03:21AM	Loading…
03:21AM	UPDATE 2-Drugmaker Indivior consults on moving primary listing from London to US (Reuters)
02:59AM	Indivior plans shifting primary listing to U.S. (Reuters)
02:00AM	Indivior Announces Q4 / FY 2023 Financial Results (PR Newswire)
Nov-13-23 09:35AM	Indivior PLC (INDV) Loses -17.71% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-09-23 07:15AM	Indivior PLC (INDV) Tops Q3 Earnings and Revenue Estimates (Zacks) -5.47%
02:05AM	Indivior Announces Q3 2023 Financial Results (PR Newswire)
Oct-23-23 11:35AM	Unveiling Indivior PLC (INDV)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com) +5.91%
02:36AM	Indivior to pay $385 million to end final Suboxone monopoly lawsuits (Reuters)
02:21AM	UPDATE 2-Indivior to pay $385 mln to end final Suboxone monopoly lawsuits (Reuters)
Oct-11-23 04:20PM	Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals (PR Newswire)
Oct-02-23 11:50AM	Indivior PLC (INDV): Unveiling Its Market Value (GuruFocus.com) -5.20%
Sep-26-23 02:30PM	Indivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in Canada (PR Newswire)
Sep-25-23 11:53AM	Unveiling Indivior PLC (INDV)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-07-23 11:42AM	Indivior PLC (INDV)'s True Worth: A Complete Analysis of Its Market Value (GuruFocus.com)
Aug-29-23 08:50AM	Indivior PLC (INDV) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
02:46PM	Loading…
Aug-21-23 02:46PM	Indivior to pay $30 million to settle health plans' Suboxone claims (Reuters) +6.05%
02:02AM	Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims (PR Newswire)
Jul-27-23 02:00AM	Indivior Announces Q2/H1 2023 Financial Results (PR Newswire)
Jun-14-23 01:53PM	Indivior Announces Four Abstracts Accepted for Presentation at the 85th Annual Scientific Meeting of the College on Problems of Drug Dependence (PR Newswire)

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INDV

Indivior Plc

Upgrade your FINVIZ experience